North America Hematuria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Treatment (Drugs, Therapies, and Others), Indication (Urinary Tract Infections, Kidney Stones, Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, and Menstruation), Type (Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, and Jogger’s Hematuria), End User (Hospitals, Clinics, and Ambulatory Surgical Centers, and Others)

Name: North America Hematuria Treatment Market
SKU: Pharmaceuticals
Rating: 4.9 (15 reviews)

Market Introduction

Hematuria is a medical condition where presence of blood is found in the urine. Generally, urine does not contain RBC and hence this can result in serious issue that may also cause kidney stones, urinary tract infection and other inherited diseases.

Moreover, the high prevalence hematuria associated indications is expected to bolster the market growth during the forecast period. However, undiagnosed cases of associated indications limit the growth of the North America hematuria treatment market.

The pandemic has offered vital growth opportunities for the players operating in the kidney disease market. The possibilities were due to the rising numbers of patients affected by the coronavirus. For instance, according to the American Society of Nephrology report, in response to COVID-19, half coronavirus positive patients admitted to intensive care unit (ICU) experience kidney failure that requires some form of dialysis. The report stated that ~ 10% to 50% of patients in ICU showed kidney failure, nearly 17% of patients needed urgent dialysis, and 46% had shown some forms of acute kidney injury (AKI). Across the North American region, the US has registered the highest numbers of patients affected by the coronavirus. Thus, the rising numbers of patients are at higher risk of getting affected for acute kidney injury (AKI), including tubular injury with septic shock, micro-inflammation, increased blood clotting, and probable direct infection of the kidney. Therefore, it is expected to raise the demand for kidney disease management products leading to market growth in the coming future.

Get more information on this report :

Market Overview and Dynamics

The North America hematuria treatment market is projected to reach US$ 419.7 million by 2028 from US$ 351.6 million in 2021; it is anticipated to grow at a CAGR of 2.6% from 2021 to 2028. Technological developments in medical devices and diagnostic procedures have led to various options for managing hematuria-associated indications, such as kidney stones, bladder stones, and urinary tract infections. The use of advanced treatment technologies is expected to enhance patient care. For instance, the implementation of robotics in surgeries for treating urolithiasis has gained popularity in recent years. Currently, Vinci Surgical System, by Intuitive Surgical Inc., is widely used in performing surgeries to treat urolithiasis. Similarly, the uptake of endourological interventions for kidney stones has increased significantly across various countries. It is also expected that advancements in associated indications are likely to support the North America hematuria treatment market during the forecast period.

Key Market Segments

In terms of type, the macroscopic hematuria segment accounted for the largest share of the North America hematuria treatment market in 2020. In terms of treatment, the drugs segment accounted for the largest share of the North America hematuria treatment market in 2020. In terms of indication, the urinary tract infection segment accounted for the largest share of the North America hematuria treatment market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the North America hematuria treatment market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the hematuria treatment market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, and Boehringer Ingelheim International GmbH.

Reasons to Buy Report

To understand the North America hematuria treatment market landscape and identify market segments that are likely to guarantee a strong return
To comprehend the ever-changing market landscape and stay ahead in competition
To efficiently plan merger and acquisition, and partnership deals in the North America hematuria treatment market by identifying segments with the most promising probable sales
To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
To obtain market revenue forecast of the North America hematuria treatment market based on various segments for the period 2021–2028

NORTH AMERICA HEMATURIA TREATMENT MARKET SEGMENTATION

By Treatment

Drugs
Therapies
Others

By Indication

By Type

Macroscopic Hematuria
Microscopic Hematuria
Idiopathic Hematuria
Jogger’s Hematuria

By End User

Hospitals
Clinics
Ambulatory Surgical Centers (ASC's)
Others

By Country

North America
US
Canada
Mexico

Companies Mentioned

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Hematuria Treatment Market – By Treatment

1.3.2 North America Hematuria Treatment Market – By Indication

1.3.3 North America Hematuria Treatment Market – By Type

1.3.4 North America Hematuria Treatment Market – By End User

1.3.5 North America Hematuria Treatment Market – By Country

2. North America Hematuria Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Hematuria Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.3 Experts Opinion

5. Hematuria Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Prevalence of Hematuria-Associated Indications

5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure

5.2 Market Restraints

5.2.1 Undiagnosed Cases of Associated Indications

5.3 Market Opportunities

5.3.1 Increasing Opportunities for Related Treatments

5.4 Future Trends

5.4.1 Rise in Preference for Advanced Therapies

5.5 Impact Analysis

6. Hematuria Treatment Market – North America Analysis

6.1 North America Hematuria Treatment Market Revenue Forecast and Analysis

7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment

7.1 Overview

7.2 North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

7.3 Drugs

7.3.1 Overview

7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Therapies

7.4.1 Overview

7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

7.5 Others

7.5.1 Overview

7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication

8.1 Overview

8.2 North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

8.3 Kidney Stones

8.3.1 Overview

8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Urinary Tract Infections (UTI)

8.4.1 Overview

8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Urethritis

8.5.1 Overview

8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.6 Blood Cancer

8.6.1 Overview

8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.7 Bladder Stones

8.7.1 Overview

8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.8 Prostate Cancer

8.8.1 Overview

8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.9 Cystitis

8.9.1 Overview

8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.10 Trauma

8.10.1 Overview

8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.11 Vigorous Exercise

8.11.1 Overview

8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.12 Polycystic Kidney Disease

8.12.1 Overview

8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.13 Endometriosis

8.13.1 Overview

8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

8.14 Menstruation

8.14.1 Overview

8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type

9.1 Overview

9.2 North America Hematuria Treatment Market, By Type 2020 & 2028 (%)

9.3 Macroscopic Hematuria

9.3.1 Overview

9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.4 Microscopic Hematuria

9.4.1 Overview

9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.5 Idiopathic Hematuria

9.5.1 Overview

9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

9.6 Jogger’s Hematuria

9.6.1 Overview

9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User

10.1 Overview

10.2 North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

10.3 Hospitals

10.3.1 Overview

10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Clinics

10.4.1 Overview

10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.5 Ambulatory Surgical Centers (ASC’s)

10.5.1 Overview

10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

10.6 Others

10.6.1 Overview

10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)

11. North America Hematuria Treatment Market – Geographic Analysis

11.1 North America: Hematuria Treatment Market

11.1.1 Overview

11.1.2 North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

11.1.2.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1 US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2 US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.3 US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.4 US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.5 US: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.2 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1 Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2 Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.3 Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.4 Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.5 Canada: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

11.1.2.3 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1 Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2 Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.3 Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.4 Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.5 Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Hematuria Treatment Market–Industry Landscape

13.1 Overview

13.2 Growth Strategies Done by the Companies in the Market, (%)

13.3 Organic Developments

13.3.1 Overview

13.4 Inorganic Developments

13.4.1 Overview

14. Company Profiles

14.1 AstraZeneca

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Bristol-Myers Squibb Company

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 F. HOFFMANN-LA ROCHE LTD.

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 GlaxoSmithKline Plc

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Janssen Pharmaceuticals

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 Merck & Co., Inc.

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 Novartis AG

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Pfizer Inc.

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Sun Pharmaceutical Industries Ltd

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 Boehringer Ingelheim International GmbH

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners

15.2 Glossary of Terms

LIST OF TABLES

Table 1. US: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 2. US: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 3. US: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 4. US: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 5. Canada: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 6. Canada: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 7. Canada: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Canada: Hematuria Treatment Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico: Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)

Table 10. Mexico: Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 11. Mexico: Hematuria Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Mexico: Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13. Organic Developments Done by Companies

Table 14. Inorganic Developments Done by Companies

Table 15. Glossary of Terms, Hematuria Treatment Market

LIST OF FIGURES

Figure 1. Hematuria Treatment Market Segmentation

Figure 2. North America Hematuria Treatment Market Overview

Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market

Figure 4. US to Show Significant Growth During Forecast Period

Figure 5. North America Hematuria Treatment Market, Industry Landscape

Figure 6. North America PEST Analysis

Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints

Figure 8. North America Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. North America Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)

Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 13. North America Hematuria Treatment Market Share by Indication 2020 & 2028 (%)

Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 26. North America Hematuria Treatment Market, by Type 2020 & 2028 (%)

Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)

Figure 31. North America Hematuria Treatment Market Share by End User 2020 & 2028 (%)

Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)

Figure 36. North America: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)

Figure 37. North America: Hematuria Treatment Market, by Country, 2021 & 2028 (%)

Figure 38. US: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Canada: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. Mexico: Hematuria Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. Impact Of COVID-19 Pandemic in North America Country Markets

Figure 42. Growth Strategies Done by the Companies in the Market, (%)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hematuria treatment market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$1500

Site License

$4000

$2000

Enterprise License

$5000

$2500

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

TABLE OF CONTENTS